Insmed | INSM - Actif À Court Terme





Actif À Court Terme Changement Date
BioMarin Pharmaceutical USD 4.61B 651.58M 2026-03
Cytokinetics USD 839.46M 77.51M 2026-03
DBV Technologies USD 212.94M 124.06M 2025-12
Gilead Sciences USD 18.64B 1.25B 2026-03
Heron Therapeutics USD 228.98M 9.08M 2026-03
Insmed USD 1.61B 181.04M 2026-03
Novartis USD 30.46B 2.26B 2025-12
Regeneron Pharmaceuticals USD 18.21B 187.3M 2026-03
Sarepta Therapeutics USD 2.31B 228.06M 2026-03
Ultragenyx Pharmaceutical USD 657M 294M 2026-03
Vertex Pharmaceuticals USD 11.73B 529.3M 2026-03